Blog - Page 4592 of 5516

FridayApr 11, 2008 6:55 pm

OTCPicks Featured Company: Intellect Neurosciences, Inc. (ILNS.OB) Obtains Notice of Allowance and Completes Grant Requirements

Intellect Neurosciences, Inc. (OTCBB: ILNS) announced that they have completed the grant requirements to obtain a European patent regarding the company's ANTISENILIN® antibodies product. They have also received a notice of allowance which states that future products to be developed by the company are approved for the treatment of Alzheimer's disease. The company's stock rose 68.75% during Thursday's trading, and an additional 7.41% April 11. The company has patents for their product, ANTISENILIN® antibodies, in Japan, China, and other countries to be disclosed. Currently, patent applications are in the approval stages in the United States. Dr. Daniel Chain, the company's…

FridayApr 11, 2008 3:39 pm

Transition Therapeutics Inc. (TTHI) Announces Licensing and Collaboration Agreement with Eli Lilly and Company

Transition Therapeutics Inc. (TTHI), based in Toronto, Ontario, Canada, is a biopharmaceutical company that develops novel therapeutics for diseases which affect large portions of the population. The focus of the company is discovering and advancing lead molecules to the most valuable and competitive targets in the industry using a state-of-the-art drug discovery engine, accelerating the development of multiple products for large disease indications, and generating shareholder value through partnership with major pharmaceutical companies. The company’s lead products are ELND005 for the treatment of Alzheimer’s disease, and TT-223 for the treatment of diabetes. The company announced a licensing and collaboration agreement…

FridayApr 11, 2008 12:40 pm

New Market China Inc. (NMCH.OB) Reviews 2007 Financial Results

New Market China, Inc., is a technology leader in the rapidly developing Chinese market specializing in software engineering, high quality software development, and digital multimedia outsourcing services delivered to customers globally. Yesterday the company’s CEO, John T. Verges, and CFO, Philip J. Rauch, conducted a webcast to review the Company's 2007 business operations and financial performance filed last week on SEC Form 10-KSB. The webcast is available in its entirety at: www.investorcalander.com. The company proudly reported total revenues of $40 million for 2007 a drastic 36% increase from only $29.5 million the prior year. Verges and Rauch reported that gross…

FridayApr 11, 2008 12:39 pm

Cell Genesys Inc. (CEGE) Sees Positive Cancer Test Results; Shares Jump 4%

Cell Genesys Inc. (CEGE) said Friday its GVAX immunotherapy treatment for recurrent prostate cancer did well in early stage clinical tests. Shares of the San Francisco, Calif.-based company were up nearly 4% to a high of $3.25 during late-day trading. Data from the trial, which enrolled 19 patients, indicate that GVAX helped 79% of the patients boost antibodies. In addition, the drug was generally well tolerated, with the most common side effects being injection-site reactions in most patients and mild flu-like symptoms in some patients, according to Cell Genesys. “We are now planning a larger randomized trial to further examine…

FridayApr 11, 2008 12:38 pm

Celgene International (CELG) Receives Approval from European Commission for the Treatment of Small Cell Lung Cancer

The European Commission (EC) today announced that Celgene’s amrubicin hydrochloride has been designated as an orphan medicinal product for the treatment of small cell lung cancer. This follows the European Medicines Agency's (EMEA) favorable opinion, issued by the EMEA's Committee for Orphan Medicinal Products (COMP). Amrubicin hydrochloride, a third generation drug, has already received approval and is now marketed in Japan for the treatment of both small cell lung cancer and non-small cell lung cancer by Nippon Kayaku. This official designation of amrubicin is important for Celgene because, once the designation is granted by the EC, it provides special incentives…

FridayApr 11, 2008 10:42 am

ZAP (ZAAP.OB) is at the Forefront of an Emerging Market

It is no secret that America and the rest of the world are heading toward a brick wall with regards to traditionally-powered automobiles. For decades, the idea of electric engines replacing current motor technology seemed far-fetched; but no more. Since 1994, ZAP has been an industry leader in alternative transportation technologies ranging from hybrid systems to hydrogen, ethanol, and fully-electric vehicle concepts. Their partnerships include a joint venture with Youngman Automotive, China's leading bus manufacturer which they call Detroit Electric, and design-collaboration with Lotus Engineering. In 2002, ZAP acquired Voltage Vehicles in a move which proved exponentially beneficial to distribution…

FridayApr 11, 2008 10:39 am

Simtrol Inc. (SMRL.OB) is “One to Watch”

Yesterday, Simtrol, Inc. (SMRL.OB) announced the release of its latest solution, Simtrol Visitor™ V1.0. This video visitation software application streamlines the scheduling process and provides the ability to monitor and record visitations. Visitor™ will be used primarily at correctional facilities to enhance the safety and cost-effectiveness of inmate visitations. Visitor™ joins Arraigner™ in the company’s telejustice suite of solutions for the government sector. Simtrol’s Curian Arraigner™ combines digital video with workflow and document management systems to avoid the logistical issues in transporting prisoners to and from the courthouse for arraignment. Both solutions utilize Simtrol’s Device Management Software (DMS) that monitors,…

FridayApr 11, 2008 10:18 am

Sunrise Telecom, Inc. (SRTI.PK) to Host Stockholder Day

Sunrise Telecom will be hosting a Stockholder Day at its corporate headquarters in San Jose, California on Wednesday, May 14, 2008 from 10:00am to 11:30am Pacific Time. Shareholders and guest can except to hear presentations by Paul Marshall, Chief Executive Officer, and Richard Kent, Chief Financial Officer. For those interested in hearing the presentations but unable to attend, a live webcast of the Stockholder Day can be accessed through the investor relations section of the company’s website, at: http://admin.sunrisetelecom.com/presentations/05142008/index.html and a replay will be available for 30 days following the event. Sunrise Telecom develops and delivers high-quality communications test and…

FridayApr 11, 2008 10:13 am

China Solar & Clean Energy Solutions, Inc. (CSOL.OB) Posts 119% Increase in Q4 Revenues

China Solar & Clean Energy Solutions Inc. (OTCBB: CSOL) today announced its financial results for the fourth quarter and fiscal year ended Dec. 31, 2007. The company distributes solar water heaters, renewable energy solutions and space heating devices in the People’s Republic of China, and attributes increases across the board to China-based acquisitions. "We are encouraged by the successful consolidation of Tianjin Huaneng with our Bazhou facility which will enable us to become one of the leading integrated solution providers of clean and renewable energy to industrial and residential customers in China. During the fourth quarter, we complemented our core…

FridayApr 11, 2008 9:47 am

StockEgg Featured Company: Skinns Inc. (SKNN. OB) Offers One Comfortably Correct Shoe with a Variety of Cover Styles

There are some markets that defy all logic about what will or will not sell. Shoppers know what they like, and have become accustomed to comfort in their daily lives. The fashion shoe segment is one such market. Shoppers are perfectly happy to jump on a trend, but are they really willing to part with a tried-and-true Armani or Jimmie Chew? Skinns Inc., a new-concept shoe company, offers a shoe designed to straddle the shoe/apparel wearer concept. The shoe itself is a cross between a comfortably correct skeleton-type shoe structure called a “BONE”, and a covering which is placed over…

Site Search

Company Search